Skip to Content

APO M250 (Mycophenolate Mofetil 250 mg)

Pill with imprint APO M250 is Blue & Pink, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Apotex Corp..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; autoimmune hepatitis; organ transplant, rejection prophylaxis; bullous pemphigoid; cogan's syndrome (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO M250

Mycophenolate mofetil 250 mg APO M250
Mycophenolate mofetil 250 mg APO M250 Front
Mycophenolate mofetil 250 mg APO M250 Back
Mycophenolate mofetil 250 mg APO M250

Mycophenolate Mofetil

Imprint:
APO M250
Strength:
250 mg
Color:
Blue & Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
gelatin
sodium lauryl sulfate
ferric oxide red
titanium dioxide
indigotindisulfonate sodium
shellac
alcohol
isopropyl alcohol
butyl alcohol
propylene glycol
ammonia
ferrosoferric oxide
potassium hydroxide
water
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0587 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide